Jan Wolf

Drug safety in thyroid eye disease – a systematic review

A. Hubalewska-Dydejczyk, G. Kahaly, I. Krämer, 2022, Expert opinion on drug safety.

A NOVEL MONOCLONAL ANTIBODY DEGRADES THE THYROTROPIN RECEPTOR AUTOANTIBODIES IN GRAVES' DISEASE.

I. Krämer, Jan Wolf, G. Kahaly, 2023, Endocrine Practice.

THYROTROPIN RECEPTOR ANTAGONISM BY A NOVEL SMALL MOLECULE: PRE-CLINICAL IN VITRO OBSERVATIONS.

L. Frommer, T. V. van Achterberg, Willem-Jan F Karstens, 2023, Thyroid : official journal of the American Thyroid Association.

Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study

L. Gooren, J. Nettleship, M. Ernst, 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease

S. Feldon, H. Elflein, L. Hadjiiski, 2023, Journal of Clinical Endocrinology and Metabolism.

A novel point-of-care device accurately measures thyrotropin in whole blood, capillary blood and serum

K. Lackner, G. Kahaly, J. König, 2022, Clinical chemistry and laboratory medicine.